strategi
antivir
drug
discoveri
elucid
imit
viral
interfer
mechan
patient
benefit
coinfect
gb
viru
c
gbvc
sinc
hivposit
individu
longterm
gbvc
viraemia
show
better
surviv
rate
patient
without
persist
gbvc
direct
influenc
gbvc
replic
shown
coinfect
experi
gbvc
human
nonpathogen
member
flavivirida
famili
replic
b
cell
therefor
gbvc
share
partli
ecolog
nich
earlier
work
demonstr
recombin
glycoprotein
gbvc
peptid
deriv
nterminu
interfer
hiv
entri
studi
investig
underli
mechan
perform
viruscel
fusion
assay
temperaturearrest
hivinfect
kinet
provid
evid
hivinhibitori
peptid
interfer
late
entri
step
engag
receptor
coreceptor
bind
competit
experi
reveal
ntermin
peptid
bind
disulfid
loop
region
transmembran
protein
conjunct
comput
analys
identifi
sequenc
similar
ntermini
gbvc
glycoprotein
similar
appear
enabl
gbvc
nterminu
interact
disulfid
loop
crucial
domain
involv
interfac
furthermor
result
present
studi
provid
initi
proof
concept
peptid
target
disulfid
loop
abl
inhibit
hiv
fusion
inspir
develop
new
class
entri
inhibitor
introduct
gb
viru
c
gbvc
common
human
viru
transmit
sexual
parenter
vertic
mother
child
infect
immunocompet
individu
usual
lead
clearanc
gbvc
viraemia
within
first
year
howev
gbvc
caus
persist
infect
approxim
case
member
flavivirida
famili
fourth
genu
term
pegiviru
recent
propos
relat
hepat
c
viru
hcv
howev
acut
persist
infect
gbvc
appear
associ
hepat
diseas
human
review
gbvc
genom
positivesens
singlestrand
rna
kb
contain
one
long
open
read
frame
orf
polyprotein
posttransl
process
cellular
viral
proteas
structur
protein
well
nonstructur
protein
industri
countri
healthi
individu
viraem
gbvc
develop
antibodi
evid
past
gbvc
infect
contrast
hcv
major
gbvc
infect
individu
occurr
antibodi
associ
clearanc
viru
howev
gbvc
elimin
document
without
appear
antibodi
indic
diagnosi
base
mere
detect
antibodi
serum
might
lead
underestim
preval
prior
infect
base
common
transmiss
rout
preval
gbvc
hcv
individu
much
higher
gener
popul
gbvc
rna
preval
rate
rang
hcv
coinfect
individu
patient
review
sever
epidemiolog
studi
metaanalysi
report
gbvc
viraemia
benefici
effect
cours
diseas
progress
surviv
furthermor
mothertochild
transmiss
gbvc
reduc
vertic
transmiss
coinfect
mother
recent
report
accident
gbvc
acquisit
via
transfus
associ
signific
reduct
mortal
hivinfect
individu
gbvc
lymphotrop
viru
replic
primarili
b
cell
therefor
occupi
least
part
ecolog
nich
sever
effect
propos
explain
interfer
includ
induct
chemokin
receptor
coreceptor
modul
prevent
cytokin
profil
reduct
cell
activ
well
downmodul
fasmedi
apoptosi
gbvc
coinfect
individu
cell
cultur
experi
reveal
direct
influenc
replic
least
two
gbvc
protein
ie
nonstructur
protein
envelop
protein
wherea
lead
decreas
receptor
express
stabil
profil
protein
prevent
entri
mechan
yet
unknown
use
synthet
peptid
present
differ
region
recent
demonstr
interfer
entri
ascrib
ntermin
part
gbvc
protein
rang
residu
accord
genbank
access
two
overlap
mer
peptid
present
amino
acid
wdrgnvtllcdcpngpwvwv
lcdcpngpwvwvpafcqavg
respect
gbvc
protein
shown
potent
ic
mm
tzmblbase
replic
assay
cell
entri
mediat
noncoval
associ
trimer
subunit
assembl
function
spike
surfac
virion
noncoval
associ
two
subunit
appear
maintain
interact
nand
ctermini
disulfid
loop
region
part
flank
nand
ctermin
heptad
repeat
region
nhr
chr
review
primari
receptor
express
surfac
monocyt
macrophag
subset
dendrit
cell
upon
engag
undergo
conform
shift
enabl
bind
chemokin
coreceptor
respect
interact
thought
induc
addit
conform
chang
envelop
trimer
result
exposur
hydrophob
fusion
peptid
insert
host
cell
membran
subsequ
nhr
chr
region
fold
back
interact
order
form
sixhelix
bundl
promot
converg
viral
cellular
membran
format
membran
pore
review
studi
aim
elucid
mechan
action
gbvc
mer
peptid
repres
residu
inhibit
entri
demonstr
peptid
act
late
coreceptor
engag
via
bind
disulfid
loop
region
new
promis
target
entri
inhibit
peptid
nacetyl
fluoresceinconjug
peptid
deriv
gbvc
glycoprotein
obtain
emc
microcollect
germani
peptid
list
tabl
synthes
standard
solidphas
fmoc
method
use
peptid
synthes
nand
ctermini
well
nterminu
peptid
acetyl
amid
respect
disulfid
peptid
ntermin
biotinyl
siteselect
attach
streptavidinco
assay
plate
cycliz
format
disulfid
bridg
two
cystein
residu
air
oxid
ph
peptid
purifi
homogen
puriti
highperform
liquid
chromatographi
verifi
laser
desorpt
mass
spectrometri
persept
biosystem
framingham
esi
mass
spectrometri
respect
peptid
stock
dissolv
dmsoh
dilut
experi
respect
buffer
medium
virion
contain
blamvpr
chimera
produc
previous
describ
briefli
cell
cotransfect
provir
dna
pcmvblamvpr
padvantag
vector
day
cultiv
viruscontain
supernat
centrifug
min
remov
cellular
debri
virioncontain
supernat
overlaid
onto
sucros
cushion
ultracentrifug
min
result
pellet
resuspend
medium
aliquot
frozen
usag
pbmc
tzmbl
cell
incub
peptid
mm
phorbol
pma
ngml
mgml
rant
nm
hr
surfac
express
analyz
use
standard
fac
stain
protocol
cell
wash
pb
incub
min
pelabel
antibodi
clone
clone
clone
bd
bioscienc
germani
subsequ
wash
cell
resuspend
pb
analyz
facscalibur
tm
flow
cytomet
bd
bioscienc
germani
virionbas
fusion
assay
perform
essenti
describ
elsewher
briefli
tzmbl
cell
infect
sucrosepurifi
virion
contain
blamvpr
ng
per
approach
temperaturearrest
state
ta
condit
bind
hi
virion
target
cell
allow
low
temperatur
via
spin
inocul
virion
ad
cell
centrifug
min
remov
unbound
viru
particl
cell
wash
cold
medium
incub
mm
peptid
respect
control
mm
mgml
mgml
mgml
h
viruscel
fusion
initi
temperatur
shift
total
hr
standard
condit
peptid
defin
control
agent
ad
cell
cultur
shortli
inocul
cell
incub
hr
subsequ
cell
wash
hbss
load
substrat
describ
manufactur
invitrogen
germani
incub
overnight
blam
activ
quantifi
use
fluoresc
plate
reader
extent
viruscel
fusion
determin
ratio
blue
nm
green
nm
emiss
upon
excit
cell
nm
bind
bind
studi
use
flow
cytometri
perform
previous
describ
briefli
supernat
contain
solubl
jrcsf
fusion
protein
fc
control
protein
obtain
transient
transfect
cell
bind
studi
cell
transient
transfect
express
plasmid
empti
plasmid
control
preincub
mm
peptid
mm
mgml
mm
inhibitor
similar
amount
solubl
fc
control
ad
min
ice
cell
wash
stain
antihuman
igg
fitcconjug
secondari
antibodi
dako
germani
min
subsequ
wash
cell
resuspend
pb
analyz
facscalibur
tm
flow
cytomet
data
collect
bd
cellquest
tm
analyz
fc
express
parallel
express
determin
stain
antibodi
clone
respect
bd
bioscienc
germani
bind
studi
immunoblot
perform
previous
describ
briefli
cell
transient
transfect
either
express
plasmid
verif
express
perform
day
transfect
via
flow
cytometri
day
cultiv
cell
resuspend
bind
buffer
mm
hepe
mm
mgcl
mm
cacl
bsa
mm
nan
ph
ml
bind
assay
either
mm
maraviroc
mm
mgml
mgml
mg
ml
nih
aid
research
refer
reagent
program
mgml
polymun
scientif
mm
fc
fc
control
mm
addit
mgml
bal
iiib
protein
nih
aid
research
refer
reagent
program
ad
incub
h
cell
wash
cold
pb
lyse
triton
contain
buffer
lysat
separ
sdspage
verifi
monoclon
antibodi
nih
aid
research
refer
reagent
program
sheep
aalto
bio
reagent
ltd
western
blot
analys
ng
use
standard
detect
achiev
hrpconjug
antihuman
antibodi
chemiluminesc
reagent
cell
transient
transfect
env
express
vector
code
precursor
surfac
express
env
trimer
empti
plasmid
control
day
cultiv
cell
incub
mg
mm
fitcconjug
peptid
h
respect
subsequ
cell
wash
resuspend
pb
analyz
flow
cytometri
use
bd
tm
lsr
ii
flow
cytomet
becton
dickinson
bioscienc
germani
flow
cytomet
data
collect
bd
facsdiva
tm
analyz
fc
express
parallel
express
determin
stain
mab
antihuman
iggfitc
pab
dako
germani
flatbottom
microtest
elisa
plate
sarstedt
germani
coat
overnight
recombin
mgml
mgml
protein
streptavidin
mgml
coat
buffer
nahco
na
co
ph
nonspecif
bind
block
block
buffer
bsa
phosphat
buffer
ph
h
room
temperatur
follow
wash
step
wash
buffer
tween
phosphat
buffer
ph
streptavidinco
plate
incub
disulfid
loop
peptid
mm
plate
incub
recombin
fc
fc
protein
serial
dilut
sampl
buffer
phosphat
buffer
ph
hr
room
temperatur
perform
competit
elisa
recombin
fc
protein
adjust
mgml
monoclon
antibodi
chessi
nih
aid
research
refer
reagent
program
polymun
austria
mm
wash
procedur
plate
incub
h
polyclon
rabbit
antihuman
igg
peroxidas
antibodi
dako
germani
sampl
buffer
wash
plate
develop
tmb
peroxidas
substrat
solut
kpl
usa
opdh
solut
dark
absorb
od
read
nm
respect
use
multichannel
photomet
elisaread
axsym
abbott
laboratori
usa
inhibitori
activ
peptid
format
measur
modifi
elisabas
method
previous
describ
briefli
polystyren
plate
coat
monoclon
antibodi
igg
describ
mgml
tri
ph
block
nonfat
milk
mm
test
peptid
control
ad
grade
concentr
well
incub
min
mm
ad
follow
incub
min
wash
wash
buffer
pb
contain
six
time
streptavidinlabel
horseradish
peroxidas
invitrogen
grand
island
ny
substrat
sigma
st
loui
mo
ad
sequenti
absorb
nm
od
measur
percent
inhibit
format
peptid
calcul
describ
globular
disord
region
identifi
use
standard
set
secondari
structur
predict
perform
use
consensu
predict
method
provid
np
server
structur
homolog
identifi
bioinfopl
meta
predict
server
model
perform
use
crystal
structur
singlevariabledomain
antibodi
pdb
code
templat
sequenc
comparison
differ
protein
perform
lalign
http
wwwchembnetorgsoftwarelalignformhtml
use
local
align
option
signal
peptid
compris
residu
remov
prior
similar
search
present
matur
protein
statist
analys
perform
use
wilcoxon
ranksum
test
twotail
shown
receptorcoreceptor
densiti
play
critic
role
effici
fusion
infect
thu
address
question
whether
two
overlap
gbvc
mer
peptid
impact
cell
surfac
present
receptor
respect
cell
surfac
present
receptor
quantifi
via
flow
cytometri
incub
primari
peripher
blood
mononuclear
cell
pbmc
heladeriv
hiv
indic
cell
express
design
tzmbl
cell
peptid
peptid
deriv
ctermin
part
residu
serv
neg
control
shown
figur
coreceptor
express
pbmc
tzmbl
cell
remain
larg
unaffect
peptid
therebi
elimin
chang
receptor
densiti
mode
action
peptid
effect
gbvc
peptid
aris
engag
find
whether
earli
late
step
entri
affect
peptid
peptid
activ
determin
engag
use
vprblactamas
vprblam
enzymebas
viruscel
fusion
assay
standard
bind
temperaturearrest
state
ta
bind
condit
respect
base
temperatur
sensit
envelopemedi
membran
fusion
low
temperatur
engag
figur
peptid
influenc
bind
cell
express
preincub
peptid
specif
control
bind
direct
bind
site
bs
subsequ
cell
incub
solubl
jrcsf
bind
analyz
flow
cytometri
use
fitcconjug
antihuman
igg
pab
bind
cell
absenc
inhibitor
set
column
show
averag
valu
three
independ
experi
perform
duplic
b
c
cell
express
preincub
peptid
fc
fc
protein
well
specif
control
bind
maraviroc
solubl
ad
cell
bind
investig
separ
cell
lysat
sdspage
visual
perform
western
blot
analys
influenc
peptid
intact
protein
bind
effici
respect
observ
normal
band
intens
gel
load
control
ment
lead
arrest
fusion
process
intermedi
state
blockad
coreceptor
bind
format
final
membran
fusion
shown
figur
effect
antibodi
interfer
initi
interact
larg
abrog
ta
condit
contrast
show
full
activ
condit
compar
known
fusion
inhibitor
like
neutral
mper
antibodi
act
engag
therefor
data
provid
evid
implement
inhibitori
activ
bind
substanti
conclus
next
assess
impact
peptid
bind
immunoblot
flow
cytometri
data
reveal
peptid
whole
ectodomain
fuse
fc
domain
human
igg
fc
show
inhibitori
activ
earlier
studi
interfer
interact
recombin
cellular
express
figur
b
relat
approach
effect
peptid
intact
protein
interact
coreceptor
express
cell
test
immunoblot
ensur
effici
bind
coreceptor
solubl
ad
simultan
use
maraviroc
coreceptor
bind
site
antibodi
respect
posit
control
reveal
clear
reduct
less
pronounc
declin
densitometr
analysi
interact
howev
normal
band
intens
data
shown
indic
bind
effici
coreceptor
respect
figur
recombin
gbvc
protein
interact
ntermin
gbvc
peptid
abrog
interact
previous
shown
target
peptid
like
locat
particl
rather
cell
surfac
particl
consist
lipid
bilay
incorpor
host
cell
protein
limit
number
function
envelop
env
trimer
averag
therefor
test
whether
peptid
interact
trimer
env
protein
express
surfac
transfect
cell
purpos
cell
transient
transfect
env
express
vector
code
precursor
envelop
bind
fitclabel
peptid
monitor
flow
cytometri
although
could
observ
background
attach
mockor
vectortransfect
cell
signific
increas
bind
cell
express
env
pretreat
figur
contrast
increas
bind
observ
neg
control
peptid
data
suggest
hivinhibitori
peptid
bind
env
interact
seem
sinc
induct
conform
chang
andor
increas
avail
engag
facilit
order
prove
assumpt
gbvc
interact
hiv
env
subsequ
bind
assay
perform
plate
immobil
subunit
envelop
protein
improv
signific
experi
use
whole
fusion
protein
fc
ligand
fc
domain
alon
serv
neg
control
ninetysixwel
plate
either
coat
recombin
fulllength
iiib
immuno
diagnost
mn
immun
technolog
express
eukaryot
cell
express
e
coli
consist
complet
iiib
abcam
truncat
ectodomain
mn
nih
mn
hydrophob
fusion
peptid
fp
transmembran
region
tm
ctermin
part
cytoplasm
tail
cp
omit
illustr
figur
wherea
bind
recombin
fc
fusion
protein
observ
fc
protein
shown
interact
variant
dosedepend
manner
figur
test
whether
gbvc
bind
hiv
ntermin
domain
competit
assay
perform
ntermin
peptid
result
experi
reveal
peptid
abrog
proteinprotein
interact
gbvc
dosedepend
manner
wherea
increas
amount
neg
control
peptid
effect
figur
left
panel
peptid
residu
gbvc
see
tabl
chosen
addit
control
due
compar
content
cystein
hydrophob
residu
noteworthi
contain
either
two
three
cystein
respect
elucid
characterist
interact
next
test
competit
abil
peptid
variant
cystein
residu
replac
serin
result
reveal
serin
variant
lost
abil
abrog
bind
suggest
cystein
residu
within
hivinhibitori
peptid
play
crucial
role
recognit
figur
right
panel
combin
find
abl
show
ntermin
region
gbvc
residu
repres
peptid
interact
cystein
residu
within
region
appear
contribut
substanti
bind
next
sought
local
peptid
bind
site
within
transmembran
protein
consist
sever
function
region
figur
fp
tm
cp
region
appear
involv
interact
gbvc
peptid
sinc
absenc
region
mn
abrog
decreas
bind
figur
test
whether
peptid
interact
either
nhr
chr
region
would
lead
blockad
format
competit
elisa
perform
assay
peptid
biotinyl
present
nhr
chr
region
respect
interact
form
stabl
structur
vitro
mab
use
captur
antibodi
gbvc
peptid
test
competit
respect
neither
abl
interfer
format
suggest
bind
site
peptid
neither
locat
nhr
chr
region
figur
dissect
bind
site
within
test
whether
peptid
compet
bind
differ
monoclon
antibodi
known
specif
includ
mab
chessi
eight
antibodi
interact
inhibit
dosedepend
manner
neg
control
figur
unspecif
bind
peptid
antibodi
observ
could
account
competit
result
data
shown
therefor
conclud
compet
consider
bind
region
repres
two
three
test
antibodi
recogn
immunodomin
disulfid
loop
region
epitop
overlap
partial
impli
peptid
bind
approxim
residu
epitop
test
shown
figur
tabl
serin
variant
lost
abil
compet
bind
target
disulfid
loop
antibodi
least
less
effici
final
perform
direct
bind
assay
biotintag
disulfid
loop
peptid
residu
accord
hiv
gbvc
fc
immobil
via
streptavidin
oxid
close
loop
linear
variant
disulfid
loop
cystein
residu
replac
serin
tabl
onto
plate
bind
grade
concentr
gbvc
fc
monitor
hrpantihuman
antibodi
inde
distinct
bind
recombin
fc
protein
disulfid
loop
peptid
evid
dose
depend
manner
wherea
fc
control
low
background
bind
observ
bind
fc
clearli
diminish
linear
serin
variant
disulfid
loop
test
figur
specif
intraand
intermolecular
interact
within
env
essenti
format
nativ
function
envelop
trimer
well
concert
conform
chang
entri
process
therefor
peptid
small
molecul
mimic
env
region
involv
interact
potenti
inhibitor
format
properli
fold
tertiari
quaternari
env
structur
exampl
strategi
potent
peptid
fusion
inhibitor
resembl
nhr
chr
sequenc
includ
enfuvirtid
henc
perform
similar
search
gbvc
ectodomain
identifi
local
similar
two
sequenc
stretch
gbvc
nterminu
nterminu
figur
sequenc
stretch
exhibit
sequenc
similar
nterminu
region
similar
also
agre
well
sequenc
region
span
peptid
residu
prove
potent
hiventri
inhibit
also
put
sequenc
similar
structur
context
highresolut
structur
inform
interact
remain
elus
review
howev
sever
mutagenesi
studi
recent
crystal
structur
suggest
nand
ctermini
interact
predominantli
disulfid
loop
region
interestingli
ntermin
sequenc
stretch
propos
involv
interact
locat
within
region
resembl
ntermin
gbvc
peptid
figur
furthermor
residu
within
trimer
propos
involv
interfac
locat
near
within
epitop
two
antibodi
whose
interact
disrupt
peptid
figur
prove
assumpt
similar
gbvc
hiv
ntermini
enabl
peptid
bind
manner
correspond
ntermin
peptid
abl
disturb
interact
therefor
assess
competit
assay
effect
peptid
residu
includ
respect
region
figur
observ
effici
compet
bind
impli
share
interact
site
surprisingli
affin
pronounc
ic
mm
peptid
ic
mm
mm
variant
peptid
still
abrog
interact
dose
depend
manner
less
effici
wildtyp
peptid
ic
mm
togeth
result
strongli
support
hypothesi
mimicri
phenomenon
ntermini
nonrel
viral
glycoprotein
gbvc
hiv
enabl
nterminu
approach
bind
site
believ
disulfid
loop
region
sinc
structur
inform
gbvc
protein
current
avail
perform
structur
predict
globular
analys
gbvc
protein
order
get
idea
whether
nterminu
access
interact
env
involv
membran
fusion
analysi
consist
suggest
presenc
fold
region
span
mn
peptid
use
elisa
well
bind
epitop
differ
monoclon
antibodi
consist
ntermin
fusion
peptid
fp
nand
cheptad
repeat
nhr
chr
connect
disulfid
loop
region
cc
loop
membran
proxim
extern
region
mper
ahel
transmembranespan
domain
tm
cytoplasm
tail
cp
b
inhibitori
activ
format
peptid
well
control
measur
elisa
use
monoclon
antibodi
detect
format
peptid
sampl
test
triplic
experi
repeat
twice
similar
result
obtain
statist
signific
achiev
measur
point
vs
c
competit
bind
peptid
differ
target
mab
immobil
recombin
mn
simultan
mab
incub
peptid
ad
increas
amount
graph
show
averag
valu
three
independ
experi
perform
duplic
vs
bind
recombin
fc
protein
fc
protein
control
cyclic
linear
peptid
present
disulfid
loop
residu
graph
show
averag
valu
three
independ
experi
perform
duplic
statist
signific
achiev
mm
concentr
protein
fc
vs
figur
local
similar
ntermini
similar
two
local
sequenc
ntermini
gbvc
detect
stretch
residu
shown
context
entir
nterminu
color
code
green
orang
respect
illustr
sequenc
peptid
prove
potent
entri
inhibit
peptid
almost
exclus
cover
sequenc
stretch
exhibit
similar
nterminu
molecul
shown
spacefil
present
function
import
region
color
b
structur
monomer
ntermin
region
exhibit
local
similar
activ
peptid
shown
blue
residu
deduc
mutat
analys
relev
interact
review
addit
shown
green
c
structur
trimer
disulfidebond
loop
recogn
antibodi
residu
shown
red
residu
addit
present
epitop
shown
orang
residu
deduc
mutat
analys
relev
interact
review
addit
shown
green
coordin
structur
present
taken
pdb
entri
respect
residu
gbvc
remain
extracellular
part
particular
ntermin
region
includ
amino
acid
compris
domain
contain
signific
amount
regular
secondari
structur
therefor
predict
form
globular
conform
figur
consequ
nterminu
like
rather
flexibl
could
plausibl
account
interact
entri
studi
explor
molecular
mechan
underli
previous
report
interfer
entri
two
overlap
peptid
deriv
ntermin
part
gbvc
envelop
protein
abl
demonstr
peptid
interfer
late
stage
entri
notion
evidenc
observ
neither
cell
surfac
express
receptor
bind
coreceptor
respect
appear
affect
instead
hivinhibitori
peptid
show
full
activ
hiv
entri
postbind
stage
agreement
find
bind
experi
reveal
interact
peptid
transmembran
protein
respons
late
membran
fusion
activ
earlier
studi
demonstr
inhibitori
region
rang
residu
gbvc
nterminu
studi
show
peptid
repres
residu
compet
protein
bind
therefor
assum
hivinhibitori
region
least
inner
domain
rang
residu
reflect
site
gbvc
interestingli
sequenc
stretch
cover
hivinhibitori
peptid
includ
strongest
conserv
part
nonglobular
nterminu
relat
flavivirida
protein
figur
particular
sever
cystein
tryptophan
highli
conserv
among
gbvc
gbva
isol
suggest
respect
protein
might
also
exhibit
similar
antilentivir
activ
align
shown
figur
also
reveal
sequenc
conserv
less
pronounc
distantli
relat
protein
gbvb
gbvd
ntermini
protein
gbvc
hcv
show
detect
sequenc
homolog
render
function
similar
rather
unlik
result
sever
experi
aim
dissect
domain
within
suggest
interact
disulfid
loop
region
disulfid
loop
region
structur
connect
nhr
chr
domain
contain
two
conserv
cystein
noteworthi
ntermin
region
contain
three
cystein
residu
well
previous
could
show
variant
peptid
cystein
replac
serin
residu
lost
hivinhibitori
capac
agreement
observ
studi
lost
abil
compet
addit
cystein
residu
within
disulfid
loop
peptid
appear
crucial
interact
recombin
protein
impli
cystein
residu
within
hivinhibitori
peptid
may
interfer
oxid
state
respect
cystein
disulfid
loop
region
varieti
evid
suggest
number
viral
envelop
glycoprotein
depend
dynam
thioldisulfid
balanc
mediat
viruscel
fusion
review
shown
bind
cell
surfaceassoci
reductas
activ
lead
cleavag
disulfid
bond
least
within
event
obligatori
trigger
membran
fusion
howev
insight
mechanist
role
disulfid
loop
cystein
fusion
reaction
still
limit
need
evalu
futur
studi
show
whether
reduc
agent
would
chang
interfer
effect
gbvc
peptid
base
cryoem
structur
inform
transmembran
protein
expect
least
partial
buri
trimer
structur
thu
transient
state
appear
valid
inhibitor
target
evidenc
number
known
fusion
inhibitor
includ
peptid
lowmolecularweight
inhibitor
inhibitor
typic
bind
nhr
chr
region
prehairpin
stage
order
prevent
format
howev
et
al
isol
natur
entri
inhibitor
virip
human
hemofiltr
target
fusion
peptid
broad
neutral
antibodi
like
bind
mper
epitop
also
transient
access
late
stage
entri
result
show
interact
peptid
disulfid
loop
region
block
fusion
thu
introduc
disulfid
loop
new
promis
target
entri
inhibit
relev
disulfid
looptarget
inhibitor
support
two
report
describ
lowmolecularweight
inhibitor
caus
resistanceconf
mutat
within
disulfid
loop
region
disulfid
loop
immunodomin
region
term
cluster
suggest
region
perman
least
transient
access
howev
unlik
peptid
studi
antibodi
direct
cluster
appear
relev
neutral
capac
differ
action
cluster
antibodi
peptid
interest
question
need
investig
one
possibl
explan
may
fact
steric
forc
prevent
globular
antibodi
gain
access
disulfid
loop
right
time
wherea
peptid
may
suffici
flexibl
purpos
howev
tempt
specul
whether
vivo
intact
ectodomain
abl
reach
disulfid
loop
peptidelik
manner
structur
inform
avail
computerbas
structur
analysi
reveal
ntermin
region
residu
appear
larg
unstructur
suggest
protein
domain
may
suffici
flexibl
interact
disulfid
loop
entri
context
experi
address
amount
circul
virusversu
possibl
exosomeassoci
process
plasma
gbvc
coinfect
hivposit
individu
appear
appropri
surfac
glycoprotein
transmembran
subunit
noncoval
associ
viral
surfac
howev
littl
known
atom
level
critic
interfac
sever
mutagenesi
studi
suggest
nand
ctermini
interact
disulfid
loop
flank
part
nhr
chr
region
structur
model
could
gener
shown
backbon
present
color
accord
secondari
structur
type
nterminu
residu
predict
adopt
globular
threedimension
structur
schemat
depict
circl
indic
ident
respect
amino
acid
cystein
may
form
disulfid
bond
shown
diamond
sequenc
posit
indic
residu
belong
peptid
investig
present
studi
highlight
red
blue
respect
overlap
residu
present
peptid
shown
magenta
howev
knowledg
dynam
interplay
differ
phase
entri
spars
know
paramet
allow
stabil
metast
conform
unligand
trimer
engag
support
rearrang
coreceptor
bind
recent
crystal
structur
core
intact
nand
ctermini
reveal
three
topolog
separ
structur
plastic
layer
conform
mobil
layer
togeth
appear
relev
buffer
movement
note
extend
nterminu
appear
particularli
flexibl
interact
viral
spike
could
easili
induc
termini
movement
plastic
termini
might
also
offer
explan
fact
interact
nterminu
mimick
flexibl
peptid
comput
experiment
data
studi
indic
ntermin
gbvc
peptid
mimic
nterminu
therefor
abl
compet
bind
disulfid
loop
region
competit
experi
confirm
peptid
correspond
ntermin
peptid
rang
residu
share
bind
region
therefor
conclud
respect
peptid
may
displac
disturb
interfac
coreceptor
bind
phenomenon
may
result
imped
concert
interplay
stabil
nativ
unbound
state
destabil
receptorbound
follow
state
complex
critic
entri
take
proper
cours
particular
bind
peptid
disulfid
loop
may
influenc
proper
disulfid
format
flexibl
need
promot
format
membran
access
essenti
lipid
mix
howev
elucid
precis
mode
action
disulfid
loop
target
peptid
interest
subject
futur
evalu
context
would
interest
consid
chimer
peptid
incorpor
sequenc
gbvc
nterminu
new
approach
enhanc
antiretrovir
activ
disulfid
looptarget
peptid
inhibitor
previous
herrera
et
al
report
peptid
deriv
nterminu
gbvc
rang
residu
well
sever
downstream
region
interact
fusion
peptid
result
suppress
replic
data
confirm
associ
gbvc
nterminu
fusion
peptid
entri
howev
plausibl
region
interact
ntermin
fusion
peptid
addit
interact
gbvc
nterminu
disulfid
loop
propos
studi
recent
xiang
et
al
report
gbvc
protein
peptid
repres
residu
interf
entri
express
jurkat
cell
howev
ad
cell
respect
peptid
inhibit
entri
unless
fuse
tat
cellular
uptak
taken
togeth
observ
support
relev
gbvc
entri
interfer
suggest
addit
nterminu
least
ctermin
part
ectodomain
involv
entri
inhibit
may
also
explain
modest
effect
cell
surfac
present
upon
express
full
length
see
cell
incub
ntermin
peptid
howev
need
evalu
extent
gbvc
particl
gbvc
infect
cell
via
bystand
effect
propos
xiang
et
al
contribut
entri
impair
conclus
propos
new
strategi
entri
inhibit
base
sequenc
resembl
ntermini
gbvc
result
demonstr
peptid
target
disulfid
loop
abl
inhibit
fusion
introduc
novel
design
concept
fusion
inhibitor
figur
multipl
sequenc
align
relat
protein
multipl
sequenc
align
protein
gbvc
black
gbva
green
gbvb
red
gbvd
blue
gbvc
isol
use
present
studi
shown
first
line
sequenc
stretch
cover
activ
peptid
underlin
second
line
show
distantli
relat
protein
chimpanze
gbvc
highlight
sequenc
diverg
within
gbvc
isol
conserv
cystein
aromat
residu
shown
bold
letter
tif
tabl
sequenc
synthet
gbvc
peptid
number
follow
gbvc
genbank
access
hiv
databas
http
www
hivlanlgov
respect
x
eaminohexano
acid
doc
